Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

by Dakin, H.A, Wordsworth, S., Rogers, C.A, Abangma, G., Raftery, J., Harding, S.P, Lotery, A.J, Downes, S.M, Chakravarthy, U., Reeves, B.C
Published 2014

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

by MacLaren, R.E, Groppe, M., Barnard, A.R, Cottriall, C.L, Tolmachova, T., Seymour, L., Reed Clark, K., During, M.J, Cremers, F.P, Black, G.C, Lotery, A.J, Downes, S.M, Webster, A.R, Seabra, M.C
Published 2014